In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomography
- PMID: 11257581
- DOI: 10.1016/s1359-6446(01)01684-1
In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomography
Abstract
Positron-emission tomography (PET) is a sensitive technique that can be used to measure drug pharmacokinetics and pharmacodynamics non-invasively in target tissues of patients. Here we focus on the application of this technology to address some of the bottlenecks in drug development, including: elucidation of pathophysiology, evaluation of pharmacokinetics, proof of principle of mechanism, and assessment of efficacy and/or response to therapy.
LinkOut - more resources
Full Text Sources
Other Literature Sources